Composition:

RABOHIX-LV Capsules contain:

• Rabeprazole Sodium IP equivalent to Rabeprazole 20 mg
• Levosulpiride — sustained-release formulation

Indications:

RABOHIX-LV used under medical supervision for:

• Gastroesophageal reflux disease (GERD)
• Acid reflux and heartburn
• Dyspepsia / acid-related indigestion
• Delayed gastric emptying associated with digestive symptoms
• Bloating and abdominal discomfort
• Symptoms such as nausea, early satiety and post-meal fullness